EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical–Immunological Phenomapping in Recurrent Pericarditis: Disentangling Biological Traits, Inflammatory State and Treatment Exposure

M A Wu iD, C Kessel iD, R Colombo iD, S Fuehner, S Berra iD, A Caforio iD, A Brucato iD, L Thurner iD

European Journal of Clinical Investigation · 2026-11 · 56 (11)

DOI: 10.1111/eci.70284 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 09.11.2026. Verfasst von M A Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, ASST Fatebenefratelli Sacco, L. Sacco Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Pericarditis, Interleukin 1 Receptor Antagonist Protein, Autoantibodies. Die Arbeit nennt 24 Literaturangaben. Gefördert von: University of Saarland, Schwiete-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenotype‐oriented management is increasingly advocated in recurrent pericarditis (RP), but it remains unclear whether clinically recognizable phenotypes reflect underlying disease biology or are shaped by current inflammation and treatment exposure. We used multidimensional phenomapping to investigate this heterogeneity.

Methods

We analysed 101 patients with idiopathic RP from the multicenter PERIPLO cohort. Factor analysis of mixed data followed by hierarchical clustering defined the index solution. Robustness was assessed across alternative specifications and models excluding treatment, inflammatory state or the IL‐1Ra axis.

Results

Three clinical–immunological patterns emerged: a predominantly remission‐state, anakinra‐treated group; a predominantly remission‐state group largely managed without IL‐1 blockade; and an active inflammatory group enriched for anti‐IL‐1Ra autoantibodies and characterized by markedly reduced measured IL‐1Ra. The two antibody‐negative groups were extensively reorganized after treatment variables were removed, whereas exclusion of the IL‐1Ra axis nearly abolished agreement with the original partition. In contrast, anti‐IL‐1Ra positivity remained consistently associated with active inflammation and very low measured IL‐1Ra.

Conclusions

In this cohort, the phenotypic heterogeneity of RP was better represented as a clinical–immunological spectrum shaped by inflammatory state and treatment exposure than as discrete, stable endotypes. The anti‐IL‐1Ra‐associated inflammatory signature was the most internally consistent biological signal. These exploratory findings require external validation, and longitudinal multidimensional phenomapping should test whether this signature can inform patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericarditisInterleukin 1 Receptor Antagonist ProteinAutoantibodiesHumansFemaleMaleRecurrencePhenotypeMiddle AgedAgedInterleukin-1InflammationAdultAntirheumatic AgentsRemission Induction

Stichwörter der Autor:innen

IL‐1 receptor antagonistanakinraautoantibodiescluster robustnessphenomappingrecurrent pericarditis

Substanzen

Interleukin 1 Receptor Antagonist ProteinAutoantibodiesInterleukin-1Antirheumatic Agents

Autor:innen und Institutionen

  • Division of Internal Medicine, ASST Fatebenefratelli Sacco, L. Sacco Hospital, Milan, Italy.
  • Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
  • Department of Pediatric Rheumatology and Immunology, Unit for Translational Inflammation Research, University Children's Hospital Muenster, Muenster, Germany.
  • Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.
  • Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Saarland University, Homburg, Germany.

ORCID-Profile: M A Wu, C Kessel, R Colombo, S Berra, A Caforio, A Brucato, L Thurner

Förderung

  • University of Saarland
  • Schwiete-Stiftung

Zitieren

APA

Wu, M. A., Kessel, C., Colombo, R., Fuehner, S., Berra, S., Caforio, A., Brucato, A., & Thurner, L. (2026). Clinical–Immunological Phenomapping in Recurrent Pericarditis: Disentangling Biological Traits, Inflammatory State and Treatment Exposure. European Journal of Clinical Investigation, 56(11). https://doi.org/10.1111/eci.70284

Vancouver

Wu MA, Kessel C, Colombo R, Fuehner S, Berra S, Caforio A, et al. Clinical–Immunological Phenomapping in Recurrent Pericarditis: Disentangling Biological Traits, Inflammatory State and Treatment Exposure. European Journal of Clinical Investigation. 2026;56(11). doi:10.1111/eci.70284

BibTeX
@article{Wu2026,
  author = {Wu, M A and Kessel, C and Colombo, R and Fuehner, S and Berra, S and Caforio, A and Brucato, A and Thurner, L},
  title = {Clinical–Immunological Phenomapping in Recurrent Pericarditis: Disentangling Biological Traits, Inflammatory State and Treatment Exposure},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {11},
  doi = {10.1111/eci.70284}
}
Kostenlos starten →